Review
Published on 26 Mar 2024
Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives
Frontiers in Hematology
doi 10.3389/frhem.2024.1373554
- 5,959 views
- 7 citations
60 Publications
volumes
Case Report
Published on 21 Mar 2024
Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
Frontiers in Hematology
doi 10.3389/frhem.2024.1345884
- 1,496 views
Opinion
Published on 18 Mar 2024
The impact of NETosis on hematological malignancies as a promising therapeutic target
Frontiers in Hematology
doi 10.3389/frhem.2024.1377806
- 2,211 views
- 2 citations
Review
Published on 08 Mar 2024
Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East
Frontiers in Hematology
doi 10.3389/frhem.2024.1347708
- 3,453 views
- 3 citations
Case Report
Published on 06 Mar 2024
Case report: Childhood erythrocytosis due to hypermanganesemia caused by homozygous SLC30A10 mutation
Frontiers in Hematology
doi 10.3389/frhem.2024.1331485
- 2,010 views
- 4 citations
Case Report
Published on 06 Mar 2024
Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib
Frontiers in Hematology
doi 10.3389/frhem.2024.1334577
- 2,401 views
- 3 citations
Review
Published on 01 Mar 2024
Exploring the intricate cross-talk between clonal expansion and the bone marrow niche
Frontiers in Hematology
doi 10.3389/frhem.2024.1334807
- 3,443 views
- 2 citations
Review
Published on 19 Feb 2024
Hypersialylation and multiple myeloma
Frontiers in Hematology
doi 10.3389/frhem.2024.1360149
- 7,621 views
- 2 citations
Review
Published on 15 Feb 2024
Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1339870
- 9,839 views
- 11 citations
Original Research
Published on 05 Feb 2024
Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis
Frontiers in Hematology
doi 10.3389/frhem.2024.1339026
- 7,266 views
- 3 citations
Review
Published on 02 Feb 2024
How artificial intelligence revolutionizes the world of multiple myeloma
Frontiers in Hematology
doi 10.3389/frhem.2024.1331109
- 6,083 views
- 5 citations
Review
Published on 25 Jan 2024
De novo drug design through artificial intelligence: an introduction
Frontiers in Hematology
doi 10.3389/frhem.2024.1305741
- 16,003 views
- 23 citations